6,110 Shares in The Chemours Company (NYSE:CC) Acquired by Coastline Trust Co

Coastline Trust Co purchased a new stake in The Chemours Company (NYSE:CC) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 6,110 shares of the specialty chemicals company’s stock, valued at approximately $124,000.

Other hedge funds also recently added to or reduced their stakes in the company. Matrix Trust Co acquired a new stake in shares of Chemours during the third quarter worth about $25,000. Blue Trust Inc. increased its position in Chemours by 166.9% during the third quarter. Blue Trust Inc. now owns 1,169 shares of the specialty chemicals company’s stock worth $26,000 after buying an additional 731 shares during the period. New Covenant Trust Company N.A. purchased a new stake in Chemours in the first quarter valued at approximately $29,000. Signaturefd LLC boosted its holdings in shares of Chemours by 163.7% in the third quarter. Signaturefd LLC now owns 1,959 shares of the specialty chemicals company’s stock valued at $40,000 after acquiring an additional 1,216 shares during the period. Finally, Headlands Technologies LLC purchased a new position in shares of Chemours during the first quarter worth approximately $42,000. 76.26% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Chemours

In other Chemours news, SVP Alvenia Scarborough sold 7,500 shares of Chemours stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $20.64, for a total value of $154,800.00. Following the transaction, the senior vice president now owns 16,645 shares in the company, valued at $343,552.80. This trade represents a 31.06 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.47% of the stock is owned by insiders.

Analyst Ratings Changes

CC has been the subject of several research reports. BMO Capital Markets upped their price target on shares of Chemours from $30.00 to $32.00 and gave the company an “outperform” rating in a research report on Monday, October 7th. Morgan Stanley decreased their target price on shares of Chemours from $30.00 to $25.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 5th. UBS Group lowered their price target on Chemours from $30.00 to $28.00 and set a “buy” rating on the stock in a report on Tuesday, August 6th. Royal Bank of Canada dropped their price objective on Chemours from $28.00 to $25.00 and set an “outperform” rating on the stock in a report on Wednesday, November 6th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Chemours from $25.00 to $18.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 6th. Five research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $24.88.

Chemours Stock Down 0.9 %

CC stock opened at $18.89 on Friday. The Chemours Company has a one year low of $15.10 and a one year high of $32.70. The stock has a market capitalization of $2.82 billion, a P/E ratio of 37.78 and a beta of 1.75. The company has a 50 day moving average price of $19.12 and a two-hundred day moving average price of $21.77. The company has a debt-to-equity ratio of 6.05, a quick ratio of 0.92 and a current ratio of 1.73.

Chemours (NYSE:CC) last released its earnings results on Monday, November 4th. The specialty chemicals company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.32 by $0.08. Chemours had a return on equity of 29.48% and a net margin of 1.34%. The firm had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.44 billion. During the same period in the prior year, the firm posted $0.64 earnings per share. The business’s quarterly revenue was up .9% compared to the same quarter last year. As a group, sell-side analysts expect that The Chemours Company will post 1.35 EPS for the current year.

Chemours Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be given a $0.25 dividend. The ex-dividend date is Friday, November 15th. This represents a $1.00 annualized dividend and a dividend yield of 5.29%. Chemours’s dividend payout ratio is presently 200.00%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.